Log in to save to my catalogue

Serocorrelates of protection against infant group B streptococcus disease

Serocorrelates of protection against infant group B streptococcus disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2179437189

Serocorrelates of protection against infant group B streptococcus disease

About this item

Full title

Serocorrelates of protection against infant group B streptococcus disease

Publisher

United States: Elsevier Ltd

Journal title

The Lancet infectious diseases, 2019-05, Vol.19 (5), p.e162-e171

Language

English

Formats

Publication information

Publisher

United States: Elsevier Ltd

More information

Scope and Contents

Contents

Group B streptococcus (GBS) is a leading cause of young infant mortality and morbidity globally, with vaccines being developed for over four decades but none licensed to date. A serocorrelate of protection against invasive disease in young infants is being considered to facilitate vaccine early licensure, followed by demonstration of efficacy asses...

Alternative Titles

Full title

Serocorrelates of protection against infant group B streptococcus disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2179437189

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2179437189

Other Identifiers

ISSN

1473-3099

E-ISSN

1474-4457

DOI

10.1016/S1473-3099(18)30659-5

How to access this item